|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to prescribing and dispensing certain controlled |
|
substances to patients diagnosed with sickle cell disease. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Sections 481.0765(a) and (b), Health and Safety |
|
Code, are amended to read as follows: |
|
(a) A prescriber is not subject to the requirements of |
|
Section 481.0764(a) if: |
|
(1) the patient has been diagnosed with cancer or |
|
sickle cell disease or the patient is receiving hospice care; and |
|
(2) the prescriber clearly notes in the prescription |
|
record that the patient was diagnosed with cancer or sickle cell |
|
disease or is receiving hospice care, as applicable. |
|
(b) A dispenser is not subject to the requirements of |
|
Section 481.0764(a) if it is clearly noted in the prescription |
|
record that the patient has been diagnosed with cancer or sickle |
|
cell disease or is receiving hospice care. |
|
SECTION 2. The change in law made by this Act applies only |
|
to a prescription issued on or after the effective date of this Act. |
|
A prescription issued before the effective date of this Act is |
|
governed by the law in effect on the date the prescription is |
|
issued, and the former law is continued in effect for that purpose. |
|
SECTION 3. This Act takes effect September 1, 2019. |